EBUS-TBNA在纵隔新生物诊断中的应用初探  

A preliminary study of application of EBUS-TBNA to diagnosis of mediastinal neoplasam

作　　者：肖贞良[1] 田坤[1] 陈章[1] 吴奎[1] 李小玉[1] 周菁[1] 

机构地区：[1]成都军区总医院呼吸内科,成都610083

出　　处：《西南国防医药》2014年第11期1166-1169,共4页Medical Journal of National Defending Forces in Southwest China

基　　金：成都军区"十二五"课题(C12034);成都军区总医院2013年新业务新技术项目

摘　　要：目的探讨支气管内超声引导经支气管针吸活检术（EBUS—TBNA）对纵隔新生物诊断的临床价值。方法收集成都军区总医院呼吸内科2013年11月-2014年4月完成EBUS．TBNA操作的11例，对EBUS．TBNA的有效性、安全性进行分析和评价。结果11例中，9例明确了病理诊断，其中1例为胸腺瘤，其余8例为小细胞肺癌等恶性疾病；另外2例病理诊断为阴性。所有患者均无严重并发症发生。结论EBUS—TBNA具有创伤小、直视操作、风险可控的优点，是一项有重要临床价值的介入肺脏病学尖端技术。Objective To investigate the clinical value of endobronchial ultrasound-guided transbronchial needle aspiration （EBUS-TBNA） in diagnosis of mediastinal neoplasam. Methods We collected the data of 11 cases with mediastinal neoplasam who received EBUS-TBNA in Department of Respiratory Diseases of General Hospital of Chengdu Military Command from November 2013 to April 2014 in order to analyze and evaluate the efficacy and safety of EBUS-TBNA. Results For all 11 cases,pathological diagnosis was confirmed in 9 cases, including thymoma in 1 case and malignant tumor such as small cell lung caneer in another 8 ones ;the other 2 ones were negative in pathological diagnosis. No severe complications occurred to any patients with EBUS-TBNA. Conclusion EBUS-TBNA, with the advantages of minimal lesion, visual operation and controllable risk, is a sophisticated interveneopulmonology technique of important clinical value.

关 键 词：EBUS—TBNA 新生物 纵隔 

分 类 号：R655.5[医药卫生—外科学]